Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pancreatic Neoplasms 7Peutz-Jeghers Syndrome 2Exocrine Pancreatic Insufficiency 2Pancreatic Intraductal Neoplasms 1Intraductal Papillary Mucinous Neoplasms 1Hereditary pancreatitis 1Hereditary Sensory and Autonomic Neuropathies 1Dysplastic Nevus Syndrome 1Diabetes Mellitus 1Colorectal Neoplasms, Hereditary Nonpolyposis 1Breast Neoplasms 1

Interventions

Secretin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Intraductal Papillary Mucinous Neoplasms × Secretin × Clear all
NCT00621556 2009-01-29

Secretin Enhanced MRCP for Evaluation of the Known or Suspected Intraductal Papillary Mucinous Neoplasms of the Pancreas

Massachusetts General Hospital

Phase 1 Terminated
2 enrolled

Intraductal Papillary Mucinous Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡